Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
暂无分享,去创建一个
M. Hudgens | Allan W. Taylor | L. Mofenson | R. Bollinger | S. Omer | P. Musoke | T. Taha | D. Jamieson | N. Kumwenda | A. Kourtis | J. B. Jackson | C. M. van der Horst | A. Ruff | N. Gupte | C. Chasela | M. Thigpen | Hana Lee | Abubaker Bedri
[1] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[2] W. Fawzi,et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial , 2012, The Lancet.
[3] B. Chi,et al. Optimal Time on HAART for Prevention of Mother-to-Child Transmission of HIV , 2011, Journal of acquired immune deficiency syndromes.
[4] Lei Wang,et al. Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.
[5] R. Atun,et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach , 2011, The Lancet.
[6] G. Aldrovandi,et al. Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. , 2011, The Journal of infectious diseases.
[7] M. Hughes,et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. , 2010, The New England journal of medicine.
[8] R. Riley,et al. Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.
[9] L. Mofenson,et al. Frequency of Gastroenteritis and Gastroenteritis-Associated Mortality With Early Weaning in HIV-1-Uninfected Children Born to HIV-Infected Women in Malawi , 2010, Journal of acquired immune deficiency syndromes.
[10] M. Maruping,et al. Hospitalization and Mortality Among Primarily Nonbreastfed Children During a Large Outbreak of Diarrhea and Malnutrition in Botswana, 2006 , 2010, Journal of acquired immune deficiency syndromes.
[11] L. Moulton,et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials , 2008, The Lancet.
[12] L. Mofenson,et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. , 2008, The New England journal of medicine.
[13] Peter B Gilbert,et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. , 2006, JAMA.
[14] C. G. Victoria,et al. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis , 2000, The Lancet.
[15] L. Stewart,et al. Systematic Reviews: Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? , 1994 .
[16] M. Hudgens,et al. Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN Study. , 2012, Contemporary clinical trials.
[17] W. Fawzi,et al. Effi cacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission ( HPTN 046 ) : a randomised , double-blind , placebo-controlled trial , 2011 .
[18] I. de Vincenzi. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. , 2011, The Lancet. Infectious diseases.
[19] P. Tattevin,et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. , 2010, The New England journal of medicine.
[20] C D Naylor,et al. Meta-analysis of controlled clinical trials. , 1989, The Journal of rheumatology.